Sphingosine kinase-1 mediates BCR/ABL-induced upregulation of Mcl-1 in chronic myeloid leukemia cells-Reference-Cited by-同舟云学术

Sphingosine kinase-1 mediates BCR/ABL-induced upregulation of Mcl-1 in chronic myeloid leukemia cells

Published:2007-06-18 Issue:57 Volume:26 Page:7904-7908
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Li Q-F,Huang W-R,Duan H-F,Wang H,Wu C-T,Wang L-S

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1210587.pdf

Reference22 articles.

1. Aichberger KJ, Mayerhofer M, Krauth MT, Skvara H, Florian S, Sonneck K et al. (2005). Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides. Blood 105: 3303–3311.

2. Bektas M, Jolly PS, Muller C, Eberle J, Spiegel S, Geilen C . (2005). Sphingosine kinase activity counteracts ceramide-mediated cell death in human melanoma cells: role of Bcl-2 expression. Oncogene 24: 178–187.

3. Bonhoure E, Pchejetski D, Aouali N, Morjani H, Levade T, Kohama T et al. (2006). Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting sphingosine kinase-1. Leukemia 20: 95–102.

4. Cortez D, Stoica G, Pierce JH, Pendergast AM . (1996). The BCR-ABL tyrosine kinase inhibits apoptosis by activating a Ras-dependent signaling pathway. Oncogene 13: 2589–2594.

5. Duan HF, Wu CT, Lu Y, Wang H, Liu HJ, Zhang QW et al. (2004). Sphingosine kinase activation regulates hepatocyte growth factor induced migration of endothelial cells. Exp Cell Res 298: 593–601.

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery and design of dual inhibitors targeting Sphk1 and Sirt1;Journal of Molecular Modeling;2023-04-14

2. Venetoclax resistance induced by activated T cells can be counteracted by sphingosine kinase inhibitors in chronic lymphocytic leukemia;Frontiers in Oncology;2023-03-20

3. BH3 mimetics and TKI combined therapy for Chronic Myeloid Leukemia;Biochemical Journal;2023-01-31

4. Advancements on the Multifaceted Roles of Sphingolipids in Hematological Malignancies;International Journal of Molecular Sciences;2022-10-22

5. Inhibition of proteasomal deubiquitinases USP14 and UCHL5 overcomes tyrosine kinase inhibitor resistance in chronic myeloid leukaemia;Clinical and Translational Medicine;2022-09